Qiagen Acquisitions

Qiagen has acquired 29 companies and its latest acquisition was Parse Biosciences, Inc. on Nov 2025

COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION
Parse Biosciences, Inc.

Nov 2025

Source »
$225M
Parse Biosciences is a Washington-based life sciences company that provides single-cell RNA sequencing solutions for the healthcare industry.
Genoox Ltd.

May 2025

Source »
$70M
Genoox is a California-based NGS analysis platform that allows clinicians to manage sequencing processes.
Verogen, Inc.

Jan 2023

Source »
$150M
Verogen is a California-based company that develops and distributes next-generation gene sequencing panels and genetic code analyzing products for the healthcare sector.
BLIRT S.A.

May 2022

Source »
undisclosed
BLIRT is a Poland-based company that develops, manufactures and commercializes recombinant enzymes for the life science industry.
NeuMoDx Molecular, Inc.

Sep 2020

Source »
$248M
NeuMoDx is a diagnostics company that offers vitro molecular diagnostic testing solutions for hospitals and clinical laboratories.

Frequently Asked Questions about Qiagen

  1. What companies did Qiagen acquire?

    Companies acquired by Qiagen include Parse Biosciences, Genoox and Verogen
  2. How many acquisitions does Qiagen have?

    Qiagen has acquired 29 companies including Parse Biosciences, Genoox and Verogen.
  1. How many acquisitions did Qiagen make in 2025?

    In 2025 Qiagen acquired 2 companies including Parse Biosciences and Genoox.